University of British Columbia

🇨🇦Canada

Country: 🇨🇦Canada

Ownership: Private

Established: 1908-01-01

Employees: 10K

Market Cap: -

Website: http://www.ubc.ca

Clinical Trials

The Effect of Xenical on Weight and Risk Factors

Phase 4

Completed

Conditions: Obesity
Heart Diseases

Interventions: Drug: Orlistat

First Posted Date: 2005-09-09

Last Posted Date: 2013-04-01

Lead Sponsor: University of British Columbia

Target Recruit Count: 25

Registration Number: NCT00152360

Locations: 🇨🇦
Healthy Heart Program/Lipid Clinic, St. Paul's Hospital, Vancouver, British Columbia, Canada

Efficacy of Botox in Patients With Idiopathic Clubfoot

Not Applicable

Completed

Conditions: Idiopathic Clubfoot (Talipes Equinovarus)

First Posted Date: 2005-09-09

Last Posted Date: 2022-05-18

Lead Sponsor: University of British Columbia

Target Recruit Count: 500

Registration Number: NCT00152334

Locations: 🇨🇦
BC Children's Hospital, Department of Orthopaedics, Vancouver, British Columbia, Canada

A Double-Blind, Randomized Control Trial Comparing Botulinum Toxin Type A (Botox) and Placebo in the Treatment of Idiopathic Clubfoot

Not Applicable

Completed

Conditions: Idiopathic Clubfoot (Talipes Equinovarus)

First Posted Date: 2005-09-09

Last Posted Date: 2018-05-17

Lead Sponsor: University of British Columbia

Target Recruit Count: 36

Registration Number: NCT00152347

Locations: 🇨🇦
BC Children's Hospital, Department of Orthopaedics, Vancouver, British Columbia, Canada

Vasomotor Symptoms (VMS) Progesterone Study: Vasomotor Symptoms and Endothelial Function - Trial of Oral Micronized Progesterone

Phase 2

Conditions: Menopause

Interventions: Drug: Oral Micronized Progesterone (Prometrium®)
Other: Placebo

First Posted Date: 2005-09-09

Last Posted Date: 2011-09-22

Lead Sponsor: University of British Columbia

Target Recruit Count: 125

Registration Number: NCT00152438

Locations: 🇨🇦
Centre for Menstrual Cycle and Ovulation Research, Vancouver, British Columbia, Canada

Rosiglitazone (Avandia®) Treatment in HIV: Its Effect on Blood Vessels

Not Applicable

Completed

Conditions: Atherosclerosis
HIV Infections

Interventions: Drug: Rosiglitazone maleate
Drug: Placebo

First Posted Date: 2005-09-02

Last Posted Date: 2009-12-09

Lead Sponsor: University of British Columbia

Target Recruit Count: 50

Registration Number: NCT00143624

Locations: 🇨🇦
St. Paul's Hospital, Vancouver, British Columbia, Canada

NRTI-Sparing Pilot Study

Phase 4

Completed

Conditions: HIV
Mitochondrial Toxicity

Interventions: Drug: lopinavir/ritonavir; nevirapine; Zidovudine; Lamivudine

First Posted Date: 2005-09-02

Last Posted Date: 2014-09-26

Lead Sponsor: University of British Columbia

Target Recruit Count: 13

Registration Number: NCT00143689

Locations: 🇨🇦
McMaster University, Hamilton, Ontario, Canada
🇨🇦
University of Ottawa Health Services, Ottawa, Ontario, Canada
🇨🇦
Clinique Medicale L'Actuel, Montreal, Quebec, Canada

and more 1 locations

D4T or Abacavir Plus Vitamin Enhancement in HIV-Infected Patients (DAVE)

Phase 2

Completed

Conditions: Acidosis, Lactic

First Posted Date: 2005-09-02

Last Posted Date: 2008-09-25

Lead Sponsor: University of British Columbia

Target Recruit Count: 80

Registration Number: NCT00143702

Locations: 🇨🇦
Positive Care Clinic, Toronto, Ontario, Canada
🇨🇦
St. Paul's Hospital, Vancouver, British Columbia, Canada

3TC or No 3TC for HIV With 3TC Resistance

Phase 4

Suspended

Conditions: HIV Infections

First Posted Date: 2005-09-02

Last Posted Date: 2008-09-25

Lead Sponsor: University of British Columbia

Target Recruit Count: 152

Registration Number: NCT00143728

Locations: 🇨🇦
St. Boniface General Hospital, Winnipeg, Manitoba, Canada
🇨🇦
McMaster University, Hamilton, Ontario, Canada
🇨🇦
Sunnybrook Hospital, Toronto, Ontario, Canada

and more 6 locations

Age of Blood in Brain Injury

Not Applicable

Completed

Conditions: Traumatic Brain Injury

First Posted Date: 2005-09-01

Last Posted Date: 2008-09-04

Lead Sponsor: University of British Columbia

Target Recruit Count: 60

Registration Number: NCT00141674

Locations: 🇨🇦
Vancouver General Hospital, Vancouver, British Columbia, Canada

A Randomized Controlled Trial of Long Versus Short Wait For Primary Total Hip and Knee Arthroplasty

Phase 4

Conditions: Osteoarthritis

First Posted Date: 2005-08-30

Last Posted Date: 2011-10-14

Lead Sponsor: University of British Columbia

Target Recruit Count: 236

Registration Number: NCT00138892

Locations: 🇨🇦
Vancouver General Hospital, Vancouver, British Columbia, Canada

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy